Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Joint Venture, Subsidiary
- Established
- 1997-04-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.cttq.com
A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics
- First Posted Date
- 2013-03-07
- Last Posted Date
- 2013-03-08
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01806376
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2013-02-21
- Last Posted Date
- 2015-05-19
- Lead Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT01795716
- Locations
- 🇨🇳
Shanghai Jiaotong University School of Medicine Ruijin Hospital, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath